Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

doi:10.1084/jem.184.5.1601

This Article

	Full Text (PDF, 555K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Pajkrt, D.
	Articles by van Deventer, S. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Pajkrt, D.
	Articles by van Deventer, S. J.


Social Bookmarking

	What's this?

ARTICLES

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

D Pajkrt, JE Doran, F Koster, PG Lerch, B Arnet, T van der Poll, JW ten Cate and SJ van Deventer
Laboratory of Experimental Internal Medicine, University of Amsterdam, The Netherlands.

High-density lipoprotein (HDL) has been found to neutralize LPS activity in vitro and in animals in vivo. We sought to determine the effects of reconstituted HDL (rHDL) on LPS responsiveness in humans in a double-blind, randomized, placebo-controlled, cross-over study. rHDL, given as a 4-h infusion at 40 mg/kg starting 3.5 h before endotoxin challenge (4 ng/kg), reduced flu-like symptoms during endotoxemia, but did not influence the febrile response. rHDL potently reduced the endotoxin-induced release of TNF, IL-6, and IL-8, while only modestly attenuating the secretion of proinflammatory cytokine inhibitors IL- 1ra, soluble TNF receptors and IL-10. In addition, rHDL attenuated LPS- induced changes in leukocyte counts and the enhanced expression of CD11b/CD18 on granulocytes. Importantly, rHDL infusion per se, before LPS administration, was associated with a downregulation of CD14, the main LPS receptor, on monocytes. This effect was biologically relevant, since monocytes isolated from rHDL-treated whole blood showed reduced expression of CD14 and diminished TNF production upon stimulation with LPS. These results suggest that rHDL may inhibit LPS effects in humans in vivo not only by binding and neutralizing LPS but also by reducing CD14 expression on monocytes.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Zhang, Z., Datta, G., Zhang, Y., Miller, A. P., Mochon, P., Chen, Y.-F., Chatham, J., Anantharamaiah, G. M., White, C. R. (2009). Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. Am. J. Physiol. Heart Circ. Physiol. 297: H866-H873 [Abstract] [Full Text]
Patel, S., Drew, B. G., Nakhla, S., Duffy, S. J., Murphy, A. J., Barter, P. J., Rye, K.-A., Chin-Dusting, J., Hoang, A., Sviridov, D., Celermajer, D. S., Kingwell, B. A. (2009). Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.. J Am Coll Cardiol 53: 962-971 [Abstract] [Full Text]
Gautier, T., Klein, A., Deckert, V., Desrumaux, C., Ogier, N., Sberna, A.-L., Paul, C., Le Guern, N., Athias, A., Montange, T., Monier, S., Piard, F., Jiang, X.-C., Masson, D., Lagrost, L. (2008). Effect of Plasma Phospholipid Transfer Protein Deficiency on Lethal Endotoxemia in Mice. J. Biol. Chem. 283: 18702-18710 [Abstract] [Full Text]
van 't Veer, C., van den Pangaart, P. S., van Zoelen, M. A. D., de Kruif, M., Birjmohun, R. S., Stroes, E. S., de Vos, A. F., van der Poll, T. (2007). Induction of IRAK-M Is Associated with Lipopolysaccharide Tolerance in a Human Endotoxemia Model. J. Immunol. 179: 7110-7120 [Abstract] [Full Text]
Bahador, M., Cross, A. S. (2007). Review: From therapy to experimental model: a hundred years of endotoxin administration to human subjects. Innate Immunity 13: 251-279 [Abstract]
Gupta, R., Plantinga, L. C., Coresh, J., Powe, N. R. (2007). Statin Use and Sepsis in Patients With Chronic Kidney Disease--Reply. JAMA 298: 284-285 [Full Text]
Birjmohun, R. S., van Leuven, S. I., Levels, J. H.M., van 't Veer, C., Kuivenhoven, J. A., Meijers, J. C.M., Levi, M., Kastelein, J. J.P., van der Poll, T., Stroes, E. S.G. (2007). High-Density Lipoprotein Attenuates Inflammation and Coagulation Response on Endotoxin Challenge in Humans. Arterioscler. Thromb. Vasc. Bio. 27: 1153-1158 [Abstract] [Full Text]
Thaveeratitham, P., Plengpanich, W., Naen-Udorn, W., Patumraj, S., Khovidhunkit, W. (2007). Effects of human apolipoprotein A-I on endotoxin-induced leukocyte adhesion on endothelial cells in vivo and on the growth of Escherichia coli in vitro. Innate Immunity 13: 58-64 [Abstract]
Thompson, P. A., Kitchens, R. L. (2006). Native High-Density Lipoprotein Augments Monocyte Responses to Lipopolysaccharide (LPS) by Suppressing the Inhibitory Activity of LPS-Binding Protein. J. Immunol. 177: 4880-4887 [Abstract] [Full Text]
Kontush, A., Chapman, M. J. (2006). Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis. Pharmacol. Rev. 58: 342-374 [Abstract] [Full Text]
Courtney, H. S., Zhang, Y.-M., Frank, M. W., Rock, C. O. (2006). Serum Opacity Factor, a Streptococcal Virulence Factor That Binds to Apolipoproteins A-I and A-II and Disrupts High Density Lipoprotein Structure. J. Biol. Chem. 281: 5515-5521 [Abstract] [Full Text]
Zheng, G., Chen, J., Li, H., Glickson, J. D. (2005). Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc. Natl. Acad. Sci. USA 102: 17757-17762 [Abstract] [Full Text]
Gupta, H., Dai, L., Datta, G., Garber, D. W., Grenett, H., Li, Y., Mishra, V., Palgunachari, M. N., Handattu, S., Gianturco, S. H., Bradley, W. A., Anantharamaiah, G.M., White, C. R. (2005). Inhibition of Lipopolysaccharide-Induced Inflammatory Responses by an Apolipoprotein AI Mimetic Peptide. Circ. Res. 97: 236-243 [Abstract] [Full Text]
Sharma, R., von Haehling, S., Rauchhaus, M., Bolger, A. P., Genth-Zotz, S., Doehner, W., Oliver, B., Poole-Wilson, P. A., Hans-Dieter, V., Coats, A. J.S., Adcock, I. M., Anker, S. D. (2005). Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins. Eur J Heart Fail 7: 479-484 [Abstract] [Full Text]
Berbee, J. F.P., Havekes, L. M., Rensen, P. C.N. (2005). Apolipoproteins modulate the inflammatory response to lipopolysaccharide. Innate Immunity 11: 97-103 [Abstract]
Stoll, L. L., Denning, G. M., Weintraub, N. L. (2004). Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 24: 2227-2236 [Abstract] [Full Text]
German, J B., Dillard, C. J (2004). Saturated fats: what dietary intake?. Am. J. Clin. Nutr. 80: 550-559 [Abstract] [Full Text]
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., Grunfeld, C. (2004). Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196 [Abstract] [Full Text]
Sprong, T., Netea, M. G., van der Ley, P., Verver-Jansen, T. J. G., Jacobs, L. E. H., Stalenhoef, A., van der Meer, J. W. M., van Deuren, M. (2004). Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria. J. Lipid Res. 45: 742-749 [Abstract] [Full Text]
Conraads, V. M., Bosmans, J. M., Schuerwegh, A. J., De Clerck, L. S., Bridts, C. H., Wuyts, F. L., Stevens, W. J., Vrints, C. J. (2003). Association of lipoproteins with cytokines and cytokine receptors in heart failure patients: Differences between ischaemic versus idiopathic cardiomyopathy. Eur Heart J 24: 2221-2226 [Abstract] [Full Text]
Kitchens, R. L., Thompson, P. A., Munford, R. S., O'Keefe, G. E. (2003). Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J. Lipid Res. 44: 2339-2348 [Abstract] [Full Text]
Hudgins, L. C., Parker, T. S., Levine, D. M., Gordon, B. R., Saal, S. D., Jiang, X.-c., Seidman, C. E., Tremaroli, J. D., Lai, J., Rubin, A. L. (2003). A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J. Lipid Res. 44: 1489-1498 [Abstract] [Full Text]
Bin, L.-H., Nielson, L. D., Liu, X., Mason, R. J., Shu, H.-B. (2003). Identification of Uteroglobin-Related Protein 1 and Macrophage Scavenger Receptor with Collagenous Structure as a Lung-Specific Ligand-Receptor Pair. J. Immunol. 171: 924-930 [Abstract] [Full Text]
Van Amersfoort, E. S., Van Berkel, T. J. C., Kuiper, J. (2003). Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock. Clin. Microbiol. Rev. 16: 379-414 [Abstract] [Full Text]
Thiemermann, C., Patel, N. S.A., Kvale, E. O., Cockerill, G. W., Brown, P. A.J., Stewart, K. N., Cuzzocrea, S., Britti, D., Mota-Filipe, H., Chatterjee, P. K. (2003). High Density Lipoprotein (HDL) Reduces Renal Ischemia/Reperfusion Injury. J. Am. Soc. Nephrol. 14: 1833-1843 [Abstract] [Full Text]
Gordon, B. R, Parker, T. S, Levine, D. M, Saal, S. D, Hudgins, L. C., Sloan, B.-J., Chu, C., Stenzel, K. H, Rubin, A. L (2003). Safety and Pharmacokinetics of an Endotoxin-Binding Phospholipid Emulsion. The Annals of Pharmacotherapy 37: 943-950 [Abstract] [Full Text]
Bisoendial, R. J., Hovingh, G. K., Levels, J. H.M., Lerch, P. G., Andresen, I., Hayden, M. R., Kastelein, J. J.P., Stroes, E. S.G. (2003). Restoration of Endothelial Function by Increasing High-Density Lipoprotein in Subjects With Isolated Low High-Density Lipoprotein. Circulation 107: 2944-2948 [Abstract] [Full Text]
Vishnyakova, T. G., Bocharov, A. V., Baranova, I. N., Chen, Z., Remaley, A. T., Csako, G., Eggerman, T. L., Patterson, A. P. (2003). Binding and Internalization of Lipopolysaccharide by Cla-1, a Human Orthologue of Rodent Scavenger Receptor B1. J. Biol. Chem. 278: 22771-22780 [Abstract] [Full Text]
Goldfarb, R. D., Parker, T. S., Levine, D. M., Glock, D., Akhter, I., Alkhudari, A., McCarthy, R. J., David, E. M., Gordon, B. R., Saal, S. D., Rubin, A. L., Trenholme, G. M., Parrillo, J. E. (2003). Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284: R550-R557 [Abstract] [Full Text]
Zweigner, J., Gramm, H.-J., Singer, O. C., Wegscheider, K., Schumann, R. R. (2001). High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98: 3800-3808 [Abstract] [Full Text]
COCKERILL, G. W., MCDONALD, M. C., MOTA-FILIPE, H., CUZZOCREA, S., MILLER, N. E., THIEMERMANN, C. (2001). High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock. FASEB J. 15: 1941-1952 [Abstract] [Full Text]
Hyka, N., Dayer, J.-M., Modoux, C., Kohno, T., Edwards, C. K. III, Roux-Lombard, P., Burger, D. (2001). Apolipoprotein A-I inhibits the production of interleukin-1{beta} and tumor necrosis factor-{alpha} by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97: 2381-2389 [Abstract] [Full Text]
Verbon, A., Dekkers, P. E. P., ten Hove, T., Hack, C. E., Pribble, J. P., Turner, T., Souza, S., Axtelle, T., Hoek, F. J., van Deventer, S. J. H., van der Poll, T. (2001). IC14, an Anti-CD14 Antibody, Inhibits Endotoxin-Mediated Symptoms and Inflammatory Responses in Humans. J. Immunol. 166: 3599-3605 [Abstract] [Full Text]
Barlage, S., Fröhlich, D., Böttcher, A., Jauhiainen, M., Müller, H. P., Noetzel, F., Rothe, G., Schütt, C., Linke, R. P., Lackner, K. J., Ehnholm, C., Schmitz, G. (2001). ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J. Lipid Res. 42: 281-290 [Abstract] [Full Text]
Cockerill, G. W., Huehns, T. Y., Weerasinghe, A., Stocker, C., Lerch, P. G., Miller, N. E., Haskard, D. O. (2001). Elevation of Plasma High-Density Lipoprotein Concentration Reduces Interleukin-1-Induced Expression of E-Selectin in an In Vivo Model of Acute Inflammation. Circulation 103: 108-112 [Abstract] [Full Text]
Harris, H. W., Gosnell, J. E., Kumwenda, Z. L. (2000). Review: The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. Innate Immunity 6: 421-430 [Abstract]
Kitchens, R. L., Thompson, P. A., O'Keefe, G. E., Munford, R. S. (2000). Plasma constituents regulate LPS binding to, and release from, the monocyte cell surface. Innate Immunity 6: 477-482 [Abstract]
de Haas, C. J. C., Poppelier, M. J. J. G., van Kessel, K. P. M., van Strijp, J. A. G. (2000). Serum Amyloid P Component Prevents High-Density Lipoprotein-Mediated Neutralization of Lipopolysaccharide. Infect. Immun. 68: 4954-4960 [Abstract] [Full Text]
Vesy, C. J., Kitchens, R. L., Wolfbauer, G., Albers, J. J., Munford, R. S. (2000). Lipopolysaccharide-Binding Protein and Phospholipid Transfer Protein Release Lipopolysaccharides from Gram-Negative Bacterial Membranes. Infect. Immun. 68: 2410-2417 [Abstract] [Full Text]
Tietge, U. J. F., Maugeais, C., Cain, W., Grass, D., Glick, J. M., de Beer, F. C., Rader, D. J. (2000). Overexpression of Secretory Phospholipase A2 Causes Rapid Catabolism and Altered Tissue Uptake of High Density Lipoprotein Cholesteryl Ester and Apolipoprotein A-I. J. Biol. Chem. 275: 10077-10084 [Abstract] [Full Text]
Rose, J. R., Mullarkey, M. A., Christ, W. J., Hawkins, L. D., Lynn, M., Kishi, Y., Wasan, K. M., Peteherych, K., Rossignol, D. P. (2000). Consequences of Interaction of a Lipophilic Endotoxin Antagonist with Plasma Lipoproteins. Antimicrob. Agents Chemother. 44: 504-510 [Abstract] [Full Text]
Deguchi, H., Fernandez, J. A., Hackeng, T. M., Banka, C. L., Griffin, J. H. (2000). Cardiolipin is a normal component of human plasma lipoproteins. Proc. Natl. Acad. Sci. USA 97: 1743-1748 [Abstract] [Full Text]
van Deuren, M., Brandtzaeg, P., van der Meer, J. W. M. (2000). Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management. Clin. Microbiol. Rev. 13: 144-166 [Abstract] [Full Text]
Kitchens, R. L., Wolfbauer, G., Albers, J. J., Munford, R. S. (1999). Plasma Lipoproteins Promote the Release of Bacterial Lipopolysaccharide from the Monocyte Cell Surface. J. Biol. Chem. 274: 34116-34122 [Abstract] [Full Text]
Azumi, S., Tanamoto, K.-i. (1999). Anti-endotoxin properties of a cinnamon bark-derived compound and its effect on the endotoxin shock model. Innate Immunity 5: 109-117 [Abstract]
de Bont, N., Netea, M. G., Demacker, P. N. M., Verschueren, I., Kullberg, B. J., van Dijk, K. W., van der Meer, J. W. M., Stalenhoef, A. F. H. (1999). Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J. Lipid Res. 40: 680-685 [Abstract] [Full Text]
Cockerill, G. W., Saklatvala, J., Ridley, S. H., Yarwood, H., Miller, N. E., Oral, B., Nithyanathan, S., Taylor, G., Haskard, D. O. (1999). High-Density Lipoproteins Differentially Modulate Cytokine-Induced Expression of E-Selectin and Cyclooxygenase-2. Arterioscler. Thromb. Vasc. Bio. 19: 910-917 [Abstract] [Full Text]
Grunfeld, C., Marshall, M., Shigenaga, J. K., Moser, A. H., Tobias, P., Feingold, K. R. (1999). Lipoproteins inhibit macrophage activation by lipoteichoic acid. J. Lipid Res. 40: 245-252 [Abstract] [Full Text]
Netea, M. G., de Bont, N., Demacker, P. N.�M., Kullberg, B. J., Jacobs, L. E.�H., Verver-Jansen, T. J.�G., Stalenhoef, A. F.�H., Van der Meer, J. W.�M. (1998). Lipoprotein(a) Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production by Human Mononuclear Cells. Infect. Immun. 66: 2365-2367 [Abstract] [Full Text]
Netea, M. G., Demacker, P. N.M., Verver-Jansen, T., Jacobs, L., Jan Kullberg, B., Stalenhoef, A. F.H., Van der Meer, J. W.M. (1997). The dense low-density lipoprotein (LDL) subfractions are more potent than buoyant LDL for binding and neutralization of lipopolysaccharide. Innate Immunity 4: 409-413 [Abstract]
Lemaire, L.C.J.M., van der Poll, T., van Lanschot, J.J.B., Levels, H.M., van der Ende, B., van Deventer, S.J.H., Gouma, D.J. (1997). Human thoracic duct lymph inhibits lipopolysaccharide-induced release of cytokines. Innate Immunity 4: 331-338 [Abstract]
Spieker, L. E., Sudano, I., Hurlimann, D., Lerch, P. G., Lang, M. G., Binggeli, C., Corti, R., Ruschitzka, F., Luscher, T. F., Noll, G. (2002). High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men. Circulation 105: 1399-1402 [Abstract] [Full Text]